Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISE trial in fibromyalgia
ISRCTN18278231Phase 4Recruiting
- Sponsor
- Canadian Institutes of Health Research
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of melatonin and pregabalin in fibromyalgia (FM) (6 arms), sponsored by Canadian Institutes of Health Research. Primary endpoint: Primary pain intensity endpoint. Started Dec 2024; status: recruiting.
02
Drugs
melatoninpregabalin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on ISRCTN18278231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18278231.